FusionQuant® Kits
Unique molecular kits providing standardization and accurate quantification of fusion gene transcripts in leukemia.

MutaScreen™ & MutaQuant™ Kits
JAK2 V617F mutation assays allow qualitative and quantitative detection of the JAK2 V617F mutation from genomic DNA isolated from peripheral blood.
These tests improve the classification of Philadelphia Negative (Ph-) myeloproliferative neoplasms.

ProfileQuant® Kits
Unique quantitative molecular kits aimed at standardizing, detecting and quantifying profile gene transcripts in human cells.

Associated products:

FusionQuant® Standards
Control and fusion gene standards for the quantification of individual fusion genes or control genes by RQ-PCR

MutaQuant™ Standards
MutaQuant™ Standards are available for specific detection of polymorphisms from both RNA and genomic DNA samples.

Control cell lines
Control cell lines are ideal tools for the control of total RNA extraction and transcription steps in the context of specific rearrangement detection by quantitative PCR.
One vial of control cell line should be processed in parallel with one batch of samples using the same reagents and protocols.

Select your product

IPSOGEN is willing to provide you with the highest quality and widest range of products for molecular diagnostic purpose. In this context, Ipsogen will be very pleased to reply to your needs by providing you customized assays under request after a feasibility study.

All IPSOGEN’s tests are manufactured under a Quality Manufacturing System compliant with ISO 13485:2003 standard.

To have more information on our customized assays, please contact us.

Following previous customers’ requests, IPSOGEN is now providing control gene standards for SRY3, Beta Globin  and ProfileQuant® Solid Tumour Marker Kit (ESR1, ERBB2 and SCUBE2 markers; on demand with a minimum of 2 weeks notification).

Please download our order form.